Skip to content

Effect aromatherapy on fatigue and quality of life in hemodialysis patients

Comparison the effect of aroma Inhalation and essence massage on fatigue and quality of life in hemodialysis patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014101819564N1
Enrollment
96
Registered
2014-12-07
Start date
2014-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease. Chronic uraemia End stage kidney disease

Interventions

Intervention 1: In group I, two drops of lavender essence with sweet orange at a ratio of 1:1 were dropped on a gas. The gas was pinned to the patient’s collar and the patient was asked to breathe nor
in case of redness, itching, swelling, and a positive test, the patient was excluded. The subjects in this group were massaged with 5 mL combination of lavender essence with sweet orange at a ratio of
In group I, two drops of lavender essence with sweet orange at a ratio of 1:1 were dropped on a gas. The gas was pinned to the patient’s collar and the patient was asked to breathe normally for 15-20
All subjects in the second group were undergone skin testing before massage with aromatic oil to ensure the absence of sensitivity
The third group (control) received only the standard care.

Sponsors

research of Deputy, Tehran of Medical Sciences University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The main conditions for inclusion were age over 18 years;. at least 1 year of hemodialysis;. dialysis three times a week;. a willingness to participate in the research;. having a healthy sense of smell and no history of aromatherapy and massage therapy during the last 9 months;. having a healthy sense of smell;. lack of allergic rhinitis or respiratory problems;. lack of skin sensitivity to aromatic herbs;. no drug abuse;. no chronic physical disorders such as debilitating cardiovascular, respiratory, hepatic or mental diseases;. The main conditions for exclusion were death of the patient during the study;. and kidney transplant.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fatigue. Timepoint: Before and one month and two months after intervention. Method of measurement: Rhoten Fatigue Scale.

Secondary

MeasureTime frame
Quality of Life. Timepoint: Before and one month and two months after intervention. Method of measurement: KDQOL - SF™1/3 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactJalalian zahra

Tehran of Medical Sciences University

zjalali58@yahoo.com+98 21 6693 7120

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026